December 2022

Surging Demand for Consumer Goods to Increase Usage of Point-of-Purchase Packaging Solutions Recent Study Reveals Growing Trend Recently published Fact.MR’s report reveals that the growing use of personal care products will fuel worldwide demand for point-of-purchase packaging solutions. This insight comes at a time when the consumer goods industry is booming, with more and more…

Nexcella, Inc. Announces Poster Presentation at the European Society for Blood and Marrow Transplantation Exciting Updates on NXC-201 CAR-T Therapy LOS ANGELES, CA, Dec. 28, 2022 (GLOBE NEWSWIRE) — Nexcella, Inc. (“Nexcella”, “Company”, “We” or “Us”), a biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology, is set to present…

Breaking Boundaries: Nexcella Inc., a Subsidiary of Immix Biopharma, to Showcase at Prestigious European Medical Conference Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will be presented in Rotterdam, Netherlands February 9-11, 2023 LOS ANGELES, CA, Dec. 28, 2022 (GLOBE NEWSWIRE) — Nexcella, Inc., a subsidiary of Immix Biopharma,…

Welcome to the World of Forex Integration Madness! The Match-Trader Platform and FX Back Office Join Forces Are you ready for some thrilling news from the world of finance and technology? Well, hold onto your hats because the integration of FX Back Office services with the Match-Trader platform is about to shake things up in…

Investigating the Acquisition of Archaea Energy Inc. by BP p.l.c Charmingly Eccentric and Full of Personality San Diego, Dec. 27, 2022 (GLOBE NEWSWIRE) Robbins LLP, a shareholder rights law firm, is currently conducting an investigation into the acquisition of Archaea Energy Inc. (NYSE: LFG) by BP p.l.c (NYSE: BP). The terms of the agreement state…

Insilico Medicine Nominates Preclinical Candidate Targeting KAT6A New York, Dec. 27, 2022 (GLOBE NEWSWIRE) — Insilico Medicine (“Insilico”), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced that the company’s drug discovery team has nominated a preclinical candidate targeting KAT6A for ER+/HER2- breast cancer therapy utilizing its end-to-end Pharma.AI platform. The Company has…

Tech Titans Unite: Global Tech Industries Group Inc. and Creatd Inc. in Talks for Epic Merger! New York, NY, Dec. 27, 2022 (GLOBE NEWSWIRE) — (GTII: OTCQB) Global Tech Industries Group, Inc. (“GTII”), www.gtii-us.com, and Creatd, Inc. (CRTD: OTCQB) (“Creatd”), today announced that they have formally begun discussions to explore synergies, including a potential merger….

Did you lose money on investments in Twist Bioscience Corporation? If so, please visit Twist Bioscience Corporation Shareholder Class Action Lawsuit Contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights NEW YORK, Dec. 27, 2022 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the…